EUVIMEDEUVIMED entdecken
Crossref

Safety of pre‐hospital peripheral vasopressors: The SPOTLESS study (Safety of PrehOspiTaL pEripheral vaSopreSsors )

Robbie Ley Greaves iD, Renee Bolot, Andrew Holgate, Clinton Gibbs iD

Emergency Medicine Australasia · 2024

DOI: 10.1111/1742-6723.14396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Emergency Medicine Australasia, 2024. Verfasst von Robbie Ley Greaves und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lifeflight Retrieval Medicine, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Vasoconstrictor Agents, Emergency Medical Services, Epinephrine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the safety and effectiveness of peripheral vasoactive drugs initiated during pre‐hospital care and retrieval missions, in Queensland, Australia.

Methods

Three years of retrospective data was gathered from two sources. Medical notes were reviewed using a search for any patient having ‘inotrope’ recorded on an electronic medical record. Each case was reviewed to include only peripheral infusions of adrenaline or noradrenaline. Clinical Governance records were searched for adverse events related to vasoactive drugs, alerted for review to ensure complete capture.

Results

A total of 418 patients received peripheral infusions of adrenaline and noradrenaline over the 3‐year period. No major complications were recorded either immediately or at Clinical Governance review. Minor complications were recorded in 4.7% of the cases, of which 3.5% occurred with peripheral vasoactives during the presence of the retrieval team. The frequency of use of peripheral vasoactives increased over the study period.

Conclusions

In this retrospective data set there were no major complications of peripheral vasoactive drugs. Minor complications were similar to in‐hospital use and related to vascular access and drug delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vasoconstrictor AgentsEmergency Medical ServicesEpinephrineHumansRetrospective StudiesQueenslandMaleFemaleMiddle AgedNorepinephrineAgedAdultPatient Safety

Stichwörter der Autor:innen

peripheralpre‐hospitalvasopressor

Substanzen

Vasoconstrictor AgentsEpinephrineNorepinephrine

Autor:innen und Institutionen

  • Lifeflight Retrieval Medicine, Brisbane, Queensland, Australia.
  • High Acuity Response Unit, Queensland Ambulance Service, Brisbane, Queensland, Australia.
  • Emergency Department, The Prince Charles Hospital, Brisbane, Queensland, Australia.
  • Research and Evaluation, Retrieval Services Queensland, Brisbane, Queensland, Australia.
  • Emergency Department, Townsville University Hospital, Townsville, Queensland, Australia.
  • College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Queensland, Australia.

ORCID-Profile: Robbie Ley Greaves, Clinton Gibbs

Zitieren

APA

Ley Greaves, R., Bolot, R., Holgate, A., & Gibbs, C. (2024). Safety of pre‐hospital peripheral vasopressors: The SPOTLESS study (Safety of PrehOspiTaL pEripheral vaSopreSsors ). Emergency Medicine Australasia. https://doi.org/10.1111/1742-6723.14396

Vancouver

Ley Greaves R, Bolot R, Holgate A, Gibbs C. Safety of pre‐hospital peripheral vasopressors: The SPOTLESS study (Safety of PrehOspiTaL pEripheral vaSopreSsors ). Emergency Medicine Australasia. 2024. doi:10.1111/1742-6723.14396

BibTeX
@article{LeyGreaves2024,
  author = {Ley Greaves, Robbie and Bolot, Renee and Holgate, Andrew and Gibbs, Clinton},
  title = {Safety of pre‐hospital peripheral vasopressors: The SPOTLESS study (Safety of PrehOspiTaL pEripheral vaSopreSsors )},
  journal = {Emergency Medicine Australasia},
  year = {2024},
  doi = {10.1111/1742-6723.14396}
}
Kostenlos starten →